Cetyl Myristoleate

Cetyl Myristoleate (CMO or CMO)

“CMO was discovered by Harry W. Diehl, working alone in his home lab….
He discovered that it was the presence of this compound in swiss albino mice that prevented them from developing joint problems”

CMO appears to function in 3 ways:

1. It serves as a surfactant and not only lubricates joints, but also lubricates the entire body, allowing muscles to move more smoothly.
2. It functions as an immune system modulator, which may be effective against auto-immune problems.
3. It functions like a fatty acid in the mediation of histamine and leukotriene response.

One 17-day course should be enough for most individuals. Research has indicated an overall success rate as high as 88.2 percent (as compared to only 16.1% in the placebo groups) when used in conjunction with supportive nutrients for cartilage growth (glucosamine hydrochloride, sea cucumber, and hydrolysed cartilage) and control of histamine and lectern response. Scientists are currently performing more research to pursue the hypothesis that the few patients who have not had success with CMO simply need more of it. Early research indicates that the effectiveness of one course will depend on the severity of your joint condition.

There are no confirmed reports of adverse side effects. There have been no reported interactions with other medications or natural substances, and other substances do not interfere with CMO; except for carbonated cola beverages, citrus juices, alcohol and caffeine, which inhibit the absorption of CMO and therefore should be eliminated during your 17-day course. Currently, it is advised that CMO is not be used by pregnant or lactating women until specific research has been done on CMO’s effects on fetuses and infants.